CAML loss causes anaphase failure and chromosome missegregation

by Liu, Yu, Malureanu, Liviu, Jeganathan, Karthik B., Tran, David Dinh, Lindquist, Lonn D., van Deursen, Jan M., Bram, Richard J.
Published 2009

A Phase I and Randomized Placebo-Controlled Phase II Trial of Bevacizumab plus Dasatinib in Patients with Recurrent Glioblastoma (GBM): Alliance/NCCTG N0872

by Galanis, Evanthia, Anderson, S. Keith, Twohy, Erin L., Carrero, Xiomara W., Dixon, Jesse G., Tran, David Dinh, Jeyapalan, Suriya A., Anderson, Daniel M., Kaufmann, Timothy J., Feathers, Ryan W., Giannini, Caterina, Buckner, Jan C., Anastasiadis, Panos Z., Schiff, David
Published in Cancer (2019)